Madrigal Pharmaceuticals Inc (MDGL)
Cash & Short-Term Investments
$838.75M
Quarterly · Period ending: · USD
MDGL Cash & Short-Term Investments
Latest reported$838.75Mperiod ending
Latest reported$838.75Mperiod ending
MDGL Quarterly Cash & Short-Term Investments ($110.02M → $838.75M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
MDGL cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 838,753,000 | |
| 817,926,000 | |
| 983,559,000 | |
| 1,109,749,000 | |
| 797,024,000 | |
| 843,068,000 | |
| 926,251,000 | |
| 998,627,000 | |
| 1,057,794,000 | |
| 1,059,063,000 | |
| 634,131,000 | |
| 232,351,000 | |
| 298,418,000 | |
| 329,477,000 | |
| 358,774,000 | |
| 153,192,000 | |
| 211,766,000 | |
| 219,953,000 | |
| 270,346,000 | |
| 299,144,000 | |
| 323,846,000 | |
| 307,224,000 | |
| 284,149,000 | |
| 335,937,000 | |
| 384,380,000 | |
| 408,510,000 | |
| 439,045,000 | |
| 453,610,000 | |
| 466,396,000 | |
| 477,825,000 | |
| 483,718,000 | |
| 488,538,000 | |
| 490,305,000 | |
| 182,825,000 | |
| 191,527,000 | |
| 62,137,000 | |
| 67,166,000 | |
| 40,127,000 | |
| 40,499,000 | |
| 39,557,855 | |
| 43,015,000 | |
| 52,042,000 | |
| 66,574,000 | |
| 88,252,000 | |
| 98,334,000 | |
| 76,606,000 | |
| 97,690,000 | |
| 119,280,000 | |
| 112,060,000 | |
| 78,787,000 | |
| 91,476,000 | |
| 53,384,000 | |
| 70,203,000 | |
| 90,394,000 | |
| 100,599,000 | |
| 55,139,000 | |
| 44,656,000 | |
| 57,390,000 | |
| 39,725,000 | |
| 50,660,000 | |
| 62,889,000 | |
| 40,233,000 | |
| 50,973,000 | |
| 54,121,000 | |
| 48,658,000 | |
| 57,917,000 | |
| 44,155,000 | |
| 51,745,000 | |
| 60,544,000 | |
| 84,753,000 | |
| 73,563,000 | |
| 58,398,000 | |
| 79,376,000 | |
| 99,206,000 | |
| 115,577,000 | |
| 48,339,000 | |
| 64,526,000 | |
| 77,876,000 | |
| 46,824,000 | |
| 58,730,000 | |
| 62,057,000 | |
| 110,015,000 |